Prenatal Genetic Diagnosis Conference

Tuesday, July 9, 2013



Managing an Unexpected Prenatal Diagnosis: Critical Considerations for Counselors, Clinicians, and Friends


Thursday, July 18, 2013

The Center for Bioethics & Human Dignity

Trinity International University

Deerfield, IL


With new prenatal screening technologies it is now possible to identify aneuploidies from cell-free DNA in maternal blood as early as 9 weeks. This means that with a simple test of a mother's blood, Down syndrome and other genetic conditions can be identified earlier and with nearly 100% accuracy.

It is more critical than ever that support structures are put into place which provide factual, balanced information and share the positive stories of delivering and raising children with Down syndrome and other genetic conditions.

 This event will also be livestreamed. More information on this will be forthcoming.

To register:

To request additional information:


Conference Topics and Speakers (bios available at registration page):

An Overview of Prenatal Testing Methods, Their Accuracy, Availability, and Use
David Prentice, PhD. Senior Fellow and Director, Life Sciences, Family Research Council

The Relationship between Prenatal Diagnosis and Termination Rates: What is Known?
Peter J. Smith, MD, MA. Associate Professor, Department of Pediatrics, University of Chicago

Legislation and Policy Initiatives Regarding Prenatal Testing and Information
Mark W Leach, JD, MA (Bioethics), Member, Stites & Harbison PLLC. President, Down Syndrome of Louisville

Research into Therapeutic Treatments for Trisomy 21 and Other Genetic or Congenital Disabilities
Byron C. Calhoun, MD, FACOG, FACS. Professor and Vice-Chair in the Department of Obstetrics and Gynecology at West Virginia University-Charleston

Communicating an Unexpected Prenatal Diagnosis: Offering Comfort and Encouragement to Families
John M. Thorp, Jr., MD. Hugh McAllister Distinguished Professor of Obstetrics and Gynecology at the University of North Carolina at Chapel Hill


6.5 Continuing Education Credits Available for Healthcare Professionals

CME Accreditation

This program has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for CME (ACCME) through joint sponsorship with the University at Buffalo School of Medicine and Biomedical Sciences and Trinity International University.

The University at Buffalo is accredited by the ACCME to sponsor CME for physicians.

The UB School of Medicine & Biomedical Sciences designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Organized and funded by:

The Jerome Lejeune Foundation, USA - Family Research Council - Medical Students for Life - The Center for Bioethics & Human Dignity